No Detail Found!

Maternal and Neonatal Outcomes in Pregnant Women with Hemoglobin E: A Cross Sectional Study

Author(s)
Rathna A Department of Obstetrics and Gynaecology, Saveetha Medical College and Hospital,Saveetha Nagar, Thandalam, Chennai - 602105, Tamil Nadu,India
Nidhi Sharma Department of Obstetrics and Gynaecology, Saveetha Medical College and Hospital Saveetha Nagar, Thandalam, Chennai - 602105, Tamil Nadu, India
Abstract
Background: Hemoglobin E (HbE) is a prevalent hemoglobin variant in Southeast Asia. While HbE trait is often asymptomatic, HbE disease and HbE/ß-thalassemia can cause clinically significant anemia, particularly during pregnancy. Despite its prevalence, the impact of HbE on maternal and fetal outcomes remains under-researched. Methods: A hospital-based cross-sectional study was conducted at Saveetha Medical College among 355 pregnant women. Hemoglobin variants were identified via HPLC. Maternal characteristics, laboratory values, and pregnancy outcomes were recorded. Statistical analyses included chi-square tests and multivariate regression. Results: HbE variants were present in 27.9% of participants: 22.0% had HbE trait, 3.4% had HbE disease, and 2.5% had HbE/ß-thalassemia. Women with HbE variants, particularly HbE disease and HbE/ß-thalassemia, had significantly higher rates of severe anemia (41.7-55.6%), blood transfusions (25-33.3%), and preterm births (25-33.3%). Early screening and management reduced complications significantly: severe anemia (8.9% vs. 38.9%), preterm birth (11.1% vs. 29.6%), and NICU admissions (6.7% vs. 22.2%). Conclusions: HbE disorders significantly impact pregnancy outcomes, even in heterozygous states. Early screening and risk-based management can dramatically improve maternal and neonatal outcomes. These findings advocate for the integration of routine HbE screening into prenatal care in high-prevalence regions to inform targeted interventions and public health policies.
Publication Details
Page(s) 334-341
DOI DOI not available
Published Journal: Journal of Neonatal Surgery, Volume: 13, Issue: 0, Year: 2024

Request the full text from PASTIC

References
Fucharoen S.,Winichagoon P. .2011 .Haemoglobinopathies in Southeast Asia. Indian Journal of Medical Research, 134 : 498-506.
Mettananda S.,Gibbons R. J.,Higgs D. R. .2016 .Understanding α-globin gene regulation and implications for the treatment of β-thalassemia. Annals of the New York Academy of Sciences, 1368(1) : 16-24.
Olivieri N. F.,Pakbaz Z.,Vichinsky E. .2011 .Hb E/β-thalassaemia: A common & clinically diverse disorder. Indian Journal of Medical Research, 134 : 522-531.
Tongsong T.,Wanapirak C.,Sirichotiyakul S. .2004 .Pregnancy outcomes among women with Hb E trait. Journal of Obstetrics and Gynaecology Research, 00201(4) : 0756-331.
Luewan S.,Tongsong T. .2008 .Outcomes of pregnancies complicated by beta-thalassemia/hemoglobin E disease. International Journal of Gynecology & Obstetrics, 11(3) : 203-205.
Leung T. Y.,Lao T. T. .2011 .Thalassaemia in pregnancy. Best Practice & Research Clinical Obstetrics & Gynaecology, 10(1) : 37-51.
Srisupundit K.,Piyamongkol W.,Tongsong T. .2010 .Hemoglobin E disorders and pregnancy outcomes. Journal of Maternal-Fetal & Neonatal Medicine, 24(9) : 1114-1117.
Leung T. Y.,Lao T. T. .2011 .Thalassaemia in pregnancy. Best Practice & Research Clinical Obstetrics & Gynaecology, 10(1) : 37-51.
Oteng-Ntim E.,Meeks D.,Seed D. .2015 .Adverse maternal and perinatal outcomes in pregnant women with sickle cell disease: Systematic review and meta-analysis. -11-607317, 125(21) : 3316-3325.
Ngim C. F.,Lai N. M.,Hong J. Y. .2019 .Thalassaemia in pregnancy: An audit of antenatal care and transfusion management in a resource-limited setting. BMC Pregnancy and Childbirth, 19(1) : 1-9.
.2014 .Management of beta-thalassaemia in pregnancy (Green-top Guideline No. , 66 : .
Srisupundit K.,Piyamongkol W.,Tongsong T. .2017 .Hemoglobin E disorders and pregnancy outcomes. Journal of Maternal-Fetal & Neonatal Medicine, 31(9) : 1159-1164.
Chaibunruang A.,Srisawat U.,Poodendaen C. .2013 .Molecular and hematological studies in a large cohort of α(0)-thalassemia in northeast Thailand: Data from a single referral center. Blood Cells, Molecules, and Diseases, 04(2) : 89-93.
World Health Organization. .2008 .Guidelines on the management of haemoglobin disorders in the European Region. , : .
0

Citations

0

Downloads

57

Views